Cargando…
Ultrasonography of Leprosy Neuropathy: A Longitudinal Prospective Study
BACKGROUND: Previous studies have shown that leprosy multi-drug therapy (MDT) does not stop the progression of nerve function impairment. There are no prospective studies investigating the evolution of nerve anatomic abnormalities after treatment. We examined leprosy patients aiming to investigate t...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5112942/ https://www.ncbi.nlm.nih.gov/pubmed/27851766 http://dx.doi.org/10.1371/journal.pntd.0005111 |
_version_ | 1782468107959271424 |
---|---|
author | Lugão, Helena Barbosa Frade, Marco Andrey Cipriani Marques-Jr, Wilson Foss, Norma Tiraboschi Nogueira-Barbosa, Marcello Henrique |
author_facet | Lugão, Helena Barbosa Frade, Marco Andrey Cipriani Marques-Jr, Wilson Foss, Norma Tiraboschi Nogueira-Barbosa, Marcello Henrique |
author_sort | Lugão, Helena Barbosa |
collection | PubMed |
description | BACKGROUND: Previous studies have shown that leprosy multi-drug therapy (MDT) does not stop the progression of nerve function impairment. There are no prospective studies investigating the evolution of nerve anatomic abnormalities after treatment. We examined leprosy patients aiming to investigate the evolution of nerve ultrasonography (US) abnormalities and the risk factors for poor outcomes after MDT. METHODOLOGY/PRINCIPAL FINDINGS: We performed bilateral US of the ulnar (U), median (M) and common fibular (CF) nerves in 9 paucibacillary (PB) and 64 multibacillary (MB) patients before and after MDT. Forty-two patients had leprosy reactions (type 1, type 2, acute neuritis) during the study. We analyzed nerve maximum cross-sectional areas (CSA), echogenicity and Doppler signal. Poor outcomes included a post-treatment CSA above normal limits with a reduction of less than 30% (U, M) or 40% (CF) from the baseline, echogenicity abnormalities or intraneural Doppler in the post-treatment study. We found that PB and patients without reactions showed significant increases in CSA at CF, whereas MB and patients with reactions had CSA reduction in some nerves after treatment (p<0.05). Despite this reduction, we observed a greater frequency of poor CSA outcomes in the MB compared to the PB (77.8% and 40.6%; p>0.05) and in the patients with reactions compared to those without (66.7% and 38.7%; p<0.05). There was significantly higher odds ratio (7.75; 95%CI: 1.56–38.45) for poor CSA outcomes only for M nerve in patients with reactions. Poor echogenicity outcomes were more frequent in MB (59.4%) compared to PB (22.2%) (p<0.05). There was significant association between poor Doppler outcomes and neuritis. Gender, disease duration, and leprosy classification were not significant risk factors for poor outcomes in CSA, echogenicity or Doppler. CONCLUSIONS/SIGNIFICANCE: US nerve abnormalities can worsen after treatment despite the leprosy classification or the presence of reactions. |
format | Online Article Text |
id | pubmed-5112942 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-51129422016-12-08 Ultrasonography of Leprosy Neuropathy: A Longitudinal Prospective Study Lugão, Helena Barbosa Frade, Marco Andrey Cipriani Marques-Jr, Wilson Foss, Norma Tiraboschi Nogueira-Barbosa, Marcello Henrique PLoS Negl Trop Dis Research Article BACKGROUND: Previous studies have shown that leprosy multi-drug therapy (MDT) does not stop the progression of nerve function impairment. There are no prospective studies investigating the evolution of nerve anatomic abnormalities after treatment. We examined leprosy patients aiming to investigate the evolution of nerve ultrasonography (US) abnormalities and the risk factors for poor outcomes after MDT. METHODOLOGY/PRINCIPAL FINDINGS: We performed bilateral US of the ulnar (U), median (M) and common fibular (CF) nerves in 9 paucibacillary (PB) and 64 multibacillary (MB) patients before and after MDT. Forty-two patients had leprosy reactions (type 1, type 2, acute neuritis) during the study. We analyzed nerve maximum cross-sectional areas (CSA), echogenicity and Doppler signal. Poor outcomes included a post-treatment CSA above normal limits with a reduction of less than 30% (U, M) or 40% (CF) from the baseline, echogenicity abnormalities or intraneural Doppler in the post-treatment study. We found that PB and patients without reactions showed significant increases in CSA at CF, whereas MB and patients with reactions had CSA reduction in some nerves after treatment (p<0.05). Despite this reduction, we observed a greater frequency of poor CSA outcomes in the MB compared to the PB (77.8% and 40.6%; p>0.05) and in the patients with reactions compared to those without (66.7% and 38.7%; p<0.05). There was significantly higher odds ratio (7.75; 95%CI: 1.56–38.45) for poor CSA outcomes only for M nerve in patients with reactions. Poor echogenicity outcomes were more frequent in MB (59.4%) compared to PB (22.2%) (p<0.05). There was significant association between poor Doppler outcomes and neuritis. Gender, disease duration, and leprosy classification were not significant risk factors for poor outcomes in CSA, echogenicity or Doppler. CONCLUSIONS/SIGNIFICANCE: US nerve abnormalities can worsen after treatment despite the leprosy classification or the presence of reactions. Public Library of Science 2016-11-16 /pmc/articles/PMC5112942/ /pubmed/27851766 http://dx.doi.org/10.1371/journal.pntd.0005111 Text en © 2016 Lugão et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Lugão, Helena Barbosa Frade, Marco Andrey Cipriani Marques-Jr, Wilson Foss, Norma Tiraboschi Nogueira-Barbosa, Marcello Henrique Ultrasonography of Leprosy Neuropathy: A Longitudinal Prospective Study |
title | Ultrasonography of Leprosy Neuropathy: A Longitudinal Prospective Study |
title_full | Ultrasonography of Leprosy Neuropathy: A Longitudinal Prospective Study |
title_fullStr | Ultrasonography of Leprosy Neuropathy: A Longitudinal Prospective Study |
title_full_unstemmed | Ultrasonography of Leprosy Neuropathy: A Longitudinal Prospective Study |
title_short | Ultrasonography of Leprosy Neuropathy: A Longitudinal Prospective Study |
title_sort | ultrasonography of leprosy neuropathy: a longitudinal prospective study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5112942/ https://www.ncbi.nlm.nih.gov/pubmed/27851766 http://dx.doi.org/10.1371/journal.pntd.0005111 |
work_keys_str_mv | AT lugaohelenabarbosa ultrasonographyofleprosyneuropathyalongitudinalprospectivestudy AT frademarcoandreycipriani ultrasonographyofleprosyneuropathyalongitudinalprospectivestudy AT marquesjrwilson ultrasonographyofleprosyneuropathyalongitudinalprospectivestudy AT fossnormatiraboschi ultrasonographyofleprosyneuropathyalongitudinalprospectivestudy AT nogueirabarbosamarcellohenrique ultrasonographyofleprosyneuropathyalongitudinalprospectivestudy |